Evolving sociodemographic trends with survival analysis in lung carcinoma: 6-year insight from Regional Cancer Center (RCC) of North India
References
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2024 May;74(3):229–63.
- Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. ICMR-NCDIRNCRP Investigator Group. Cancer statistics, 2020: report from national cancer registry programme, India. JCO Global oncology. 2020 Jul; 6: 1063–75.
- Nath A, Sathishkumar K, Das P, Sudarshan KL, Mathur P. A clinicoepidemiological profile of lung cancers in India–Results from the National Cancer Registry Programme. Indian Journal of Medical Research. 2022 Feb 1;155(2):264–72.
- Sathish kumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India. Indian journal of medical research. 2022 Oct 1;156 (4&5):598–607.
- Dey A, Biswas D, Saha SK, Kundu S, Kundu S, Sengupta A. Comparison study of clinicoradiological profile of primary lung cancer cases: An Eastern India experience. Indian J Cancer 2012;49:89–95.
- Mandal SK, Singh TT, Sharma TD, Amrithalingam V. Clinico-pathology of lung cancer in a regional cancer center in Northeastern India. Asian Pac J Cancer Prev 2013
- Kaur H, Sehgal IS, Bal A, Gupta N, Behera D, Das A, et al. Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key. Indian J Cancer 2017;54:285–90.
- Mohan A, Garg A, Gupta A, Sahu S, Choudhari C, Vashistha V, et al. Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center. Lung India. 2020 May 1;37(3):190–7.
- Murali AN, Radhakrishnan V, Ganesan TS, Rajendranath R, Ganesan P, Selvaluxmy G,et al. Outcomes in lung cancer: 9-year experience from a tertiary cancer center in India. Journal of Global Oncology. 2017 Oct;3(5):459–68.
- Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, et al. Cancer mortality in India: a nationally representative survey. The Lancet. 2012 May 12; 379(9828):1807–16.
- Malik PS, Sharma MC, Mohanti BK, Shukla NK, Deo S, Mohan A, et al. Clinico-pathological profile of lung cancer at AIIMS: A changing paradigm in India. Asian Pac J Cancer Prev 2013;14:489–94
- Garg A, Iyer H, Jindal V, Vashistha V, Ali A, Jain D, et al. Prognostic factors for treatment response and survival outcomes after first-line management of Stage 4 non-small cell lung cancer: A real-world Indian perspective. Lung India. 2022 Mar 1; 39(2):102–9.
- Sehgal SA, Malik G, Sachdeva A, Chauhan AK, Kaushal V, Kaur P, Atri R. Pretreament neutrophillymphocyte ratio (NLR): a felicitous prognostic marker in carcinoma lung. Journal of Cancer Research and Therapeutics. 2023 Jan 1;19(Suppl 2):S719–23.
- Radzikowska E, Głaz P, Roszkowski K. Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002;13:1087–93.
- Blanchon F, Grivaux M, Asselain B, Lebas FX, Orlando JP, Piquet J, et al. 4-year mortality in patients with non-small-cell lung cancer: Development and validation of a prognostic index. Lancet Oncol 2006;7:829–36.
- Krishnamurthy A, Vijayalakshmi R, Gadigi V, Ranganathan R, Sagar TG. The relevance of “nonsmoking-associated lung cancer” in India: A single-centre experience. Indian J Cancer 2012;49:82–8.
- Sheikh S, Shah A, Arshed A, Makhdoomi R, Ahmad R. Histological pattern of primary malignant lung tumours diagnosed in a tertiary care hospital: 10 year study. Asian Pac J Cancer Prev. 2010 Jan 1;11(5):1341–6.
- Rajappa S, Gundeti S, Talluri MR, Digumarti R. Chemotherapy for advanced lung cancer: A 5-year experience. Indian J Cancer 2008;45:20–6.
- Gupta R, Chowdhary I, Singh P. Clinical, Radiological and Histological profile of Primary Lung Carcinomas. JK science. 2015 Jul 1;17(3).
- Vasudevan S, Krishna V, Mehta A. Lung cancer in non-smokers: clinicopathological and survival differences from smokers. Cureus. 2022 Dec;14(12).
- Darling HS, Viswanath S, Singh R, Ranjan S, Pathi N, Rathore A, Pathak A, Sud R. A clinicoepidemiological, pathological, and molecular study of lung cancer in Northwestern India. Journal of Cancer Research and Therapeutics. 2020 Jul 1;16(4):771–9.
- Ramani V, Bijit C, Vinu S, Belagutti JS, Radheshyam N. Clinicopathological profile of lung cancers at an institute from South India—A record based retrospective cohort study. Advances in Lung Cancer. 2020 Sep 30;9(03):41–54.
- Bhatti V, Kwatra KS, Puri S, Calton N. Histopathological spectrum and immunohistochemical profile of lung carcinomas: A 9-year study from a tertiary hospital in North India. International Journal of Applied and Basic Medical Research. 2019 Jul 1;9(3):169–75.
- Chordia RR, Chaudhari CB. Study of clinical profile of lung cancer cases at a tertiary care center. MedPulse International Journal of Medicine. September 2019; 11(3): 227–30.
- Thakkar D, Damor P, Vithalani K. Clinicopathological profile of patients with bronchogenic carcinoma at a tertiary care center in Western India. Indian J Respir Care 2019;8:80–3.
Language: English
Submitted on: Apr 4, 2025
Accepted on: Nov 4, 2025
Published on: Mar 28, 2026
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Garima Malik, Shailley, Ashok K. Chauhan, Paramjeet Kaur, Rajeev Atri, Rakesh Dhankar, Narayan P Patel, N. Balasubramanian, Sachin Sehgal, Rakesh Malik, Aman Sachdeva, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.